A new approach in immunotherapy with Vaccinia oncolysates
Wallack, M.K.
Surgical Forum 28: 160-161
1977
ISSN/ISBN: 0071-8041 PMID: 617403 Document Number: 119868
Document emailed within 1 workday
Related Documents
Barnavon, Y.; Iwaki, H.; Bash, J.A.; Wallack, M.K. 1988: Vaccinia colon oncolysate immunotherapy for murine hepatic metastases can be modulated with low-dose interleukin-2. Third place winner: Conrad Jobst Award American Surgeon 54(12): 696-701Topa, P.K.; Rao, K.V. 1976: Extraction of vaccinia virus and purification of vaccinia elementary body suspension with Mafron 11 Indian Journal of Medical Research 64(10): 1421-1431
Wallack, M.K. 1979: The treatment of advanced malignant melanoma with vaccina oncolysates La Nouvelle Presse Medicale 8(23): 1919-1921
Ghanta, V.K.; Hiramoto, N.S.; Solvason, H.B.; Soong, S.J.; Hiramoto, R.N. 1990: Conditioning: a new approach to immunotherapy Cancer Research 50(14): 4295-4299
Papermaster, B.W.; Kaltenbach, M.L. 1978: Lymphokine preparations: a new approach to cancer immunotherapy Missouri Medicine 75(12): 607-609; 612
Richman, S.P.; Mavligit, G.M.; Wolk, R.; Gutterman, J.U.; Hersh, E.M. 1975: Epilesional scarification. Preliminary report of a new approach to local immunotherapy with BCG JAMA 234(12): 1233-1235
Yamasaki, T.; Kikuchi, H. 1989: An experimental approach to specific adoptive immunotherapy for malignant brain tumors Nihon Geka Hokan. Archiv für Japanische Chirurgie 58(6): 485-492
Bereznaya, N.M.; Chekhun, V.F. 2007: Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy Experimental Oncology 29(1): 2-12
Manzotti, G.; Riario-Sforza, G.G.; Dimatteo, M.; Scolari, C.; Makri, E.; Incorvaia, C. 2016: Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment European Annals of Allergy and Clinical Immunology 48(6): 224-227
Moscato, G.; Rossi, G.; Dellabianca, A.; Pisati, A.; Vinci, G.; Biale, C. 1991: Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a double-blind comparison with parenteral immunotherapy Journal of Investigational Allergology and Clinical Immunology 1(6): 383-394
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113
Beaud, G.; Mars, M.; Vassef, A. 1987: Vaccinia virus as a vector Developments in Biological Standardization 66: 49-54
Haim, S. 1976: Accidental vaccinia of the vulva Cutis 17(2): 308-309
Núñez, J.A.; Cuesta, U. 2000: Local conjunctival immunotherapy: the effect of dermatophagoides pteronyssinus local conjunctival immunotherapy on conjunctival provocation test in patients with allergic conjunctivitis Allergologia et Immunopathologia 28(6): 301-306
Ghendon, Y.Z.; Rozina, E.E.; Marchenko, A.T. 1973: On the "neuropathogenicity" mechanism of vaccinia virus Acta Virologica 17(2): 169
Ehrengut, W. 1971: The intradermal vaccinia test is specific Deutsche Medizinische Wochenschrift 96(24): 1062-1063
Stoop, J.W. 1972: A patient with progressive and generalized vaccinia Nederlands Tijdschrift Voor Geneeskunde 116(44): 1981-1984
Smithwick, E.M.; Steiner, M.; Quick, J.D. 1972: Vaccinia virus and tuberculin reactivity Pediatrics 50(4): 660-661
Watanabe, T.; Sato, T.; Ichikawa, M.; Sakuma, J.; Saito, K.; Nagatani, T. 2011: Surgical approach for craniopharyngioma bifrontal basal interhemispheric approach/extended endonasal endoscopic approach No Shinkei Geka. Neurological Surgery 39(9): 849-857
Korbecki, M.; Bankowski, A.; Filczak, K.; Klimek, A. 1985: Dipyridamole as an inhibitor of vaccinia virus replication Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 1: 29-32